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KinesinTrafﬁcking kinesin proteins (TRAKs) 1 and 2 are kinesin-associated proteins proposed to function in excitable
tissues as adaptors in anterograde trafﬁcking of cargoes including mitochondria. They are known to associate
with N-acetylglucosamine transferase and the mitochondrial rho GTPase, Miro. We used confocal imaging,
Förster resonance energy transfer and immunoprecipitations to investigate association between TRAKs1/2,
N-acetylglucosamine transferase, the prototypic kinesin-1, KIF5C, and Miro. We demonstrate that in COS-7
cells, N-acetylglucosamine transferase, KIF5C and TRAKs1/2 co-distribute. Förster resonance energy transfer
was observed between N-acetylglucosamine transferase and TRAKs1/2. Despite co-distributing with KIF5C
and immunoprecipitations demonstrating a TRAK1/2, N-acetylglucosamine transferase and KIF5C ternary
complex, no Förster resonance energy transfer was detected between N-acetylglucosamine transferase and
KIF5C. KIF5C, N-acetylglucosamine transferase, TRAKs1/2 and Miro formed a quaternary complex. The
presence of N-acteylglucosamine transferase partially prevented redistribution of mitochondria induced by
trafﬁcking proteins 1/2 and KIF5C. TRAK2 was a substrate for N-acetylglucosamine transferase with TRAK2
(S562) identiﬁed as a site of O-N-acetylglucosamine modiﬁcation. These ﬁndings substantiate trafﬁcking
kinesin proteins as scaffolds for the formation of a multi-component complex involved in anterograde
trafﬁcking of mitochondria. They further suggest that O-glycosylation may regulate complex formation.ent protein kinase II; EAA1,
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TRAK1, also known as β O-linked N-acetylglucosamine transferase
interacting protein 106 (OIP106) and Milt1 (Milton1), and TRAK2,
also known as GABAA receptor interacting factor-1 (GRIF-1), OIP98 or
Milt2, are members of a coiled-coil gene family that may also include
Huntingtin-associated protein 1 (HAP1). TRAK1 and TRAK2 are
predominantly expressed in excitable tissues. They have been
proposed to function as kinesin adaptor proteins facilitating ante-
rograde trafﬁcking of deﬁned cargoes [1,2] Several putative cargoes
have been identiﬁed. These include the inhibitory γ-aminobutyric
acidA (GABAA) neurotransmitter receptors [3,4] and Kir2.1 inwardlyrectifying potassium channels [5]. Most evidence accrued to date
however suggests that both TRAK1 and TRAK2 act as kinesin adaptor
proteins mediating anterograde transport of mitochondria. The
Drosophila orthologue of TRAK1 and/or TRAK2 is Milton [6].
Homozygous milton null Drosophila are blind. In their photoreceptor
cells, central and peripheral neurones, mitochondria are accumulated
in neuronal cell bodies, whereas synaptic terminals and axons are
depleted of mitochondria [6–8]. Milton co-localizes with mitochon-
dria in various Drosophila neuronal cell types [6]. In heterologous
expression systems, Milton, TRAK1 and TRAK2 co-distribute with
mitochondria [1,2,8,9]. Further, co-expression of TRAK1, TRAK2 or
Milton with kinesin heavy chain results in the redistribution of
mitochondria to regions at the tips of cellular processes where both
TRAK1, TRAK2 or Milton and kinesin heavy chains are co-localized
[2,8]. TRAK2 has been shown to co-distribute with mitochondria in
cultured hippocampal neurones [10]. Recently a mitochondrial
acceptor for Milton, TRAK1 and TRAK2 was identiﬁed, the mitochon-
drial membrane rho GTPase, Miro [6,10,11]. Immunoprecipitations
and co-localization studies demonstrated an association in vitro of
Milton, TRAK1 and TRAK2 with either Miro-1 or Miro-2 [6,10,11]; one
in vivo study showed co-immunoprecipitation of TRAK2 and Miro
from lysates of rat brain [10]. Over-expression of Miro-1 in
hippocampal neurones recruited TRAK2 to mitochondria resulting in
their enhanced distribution towards the distal ends of processes
suggestive of facilitated anterograde transport [10]. Conversely,
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Miro-1 binding fragment, reduced mitochondrial transport into
processes [10]. TRAK2 was recently reported to associate with other
mitochondrial proteins that include mitofusin, a dynamin family
GTPase, implicated in mitochondrial fusion [12], Pink1, a mitochon-
drial kinase [13] and hypoxia up-regulated mitochondria movement
regulator (HUMMR) [14]. Thus there is a proven role for TRAK1 and
TRAK2 and its mitochondrial acceptor, Miro-1, in mitochondrial
trafﬁcking machinery in neurones.
In addition to associatingwith kinesin andMiro, TRAK1 and TRAK2
interact with the post-translational modiﬁcation enzyme, β O-linked
N-acetylglucosamine transferase (OGT) [15]. Indeed both TRAK1 and
TRAK2 were originally identiﬁed from a yeast two-hybrid screen as
OGT interacting proteins (OIPs), hence the alternative nomenclature,
OIP106 (TRAK1) and OIP98 (TRAK2) [15]. TRAK1 and TRAK2 have also
been implicated in regulating endosome to lysosome trafﬁcking by
virtue of their association in HeLa and pheochromocytoma (PC) 12
cells with hepatocyte growth factor-regulated tyrosine kinase
substrate (Hrs) [16,17]. Also, over-expression of Hrs recruited
TRAK2 to Hrs positive endosomal compartments [10]. It was
suggested therefore that TRAK2 may participate in microtubule-
based transport of early endosomes by acting as an adaptor linking
Hrs-containing endosomes to kinesin [16].
Here, we have investigated the interactions between TRAK1 and
TRAK2, nucleocytoplasmic OGT (nOGT) and the prototypic kinesin
heavy chain, KIF5C. We provide evidence to show that the three
proteins form a ternary complex that is mediated by the TRAK
proteins. We also demonstrate that TRAK2, nOGT, KIF5C, and the
mitochondrial rho GTPase, Miro, a TRAK1/TRAK2 cargo, form a
quaternary complex. The association of nOGT with KIF5C and TRAK1
or TRAK2 impairs mitochondrial redistribution induced by KIF5C and
TRAK1/2 suggesting that nOGT may play a role in the formation of
TRAK2/mitochondrial or TRAK2/KIF5C interactions and thereby
mitochondrial trafﬁcking processes.
2. Materials and methods
2.1. Constructs and antibodies
pCISTRAK2 (formerly pCISGRIF-1, splice form GRIF-1a hereafter
referred to as TRAK2) was as previously described [2]. To simplify
nomenclature, plasmids encoding proteins that were tagged with
ﬂuorescent proteins at the N-terminus were named with the tag name
preceding the protein, i.e., pYFP-KIF5C encodes KIF5Cwith the EYFP tag at
theN-terminus. Conversely, plasmids encoding proteins thatwere tagged
at the C-terminus were named with the tag name following the protein,
i.e., pKIF5C-EYFP. pECFP-TRAK2 (formerly pECFP-GRIF-1), pcDNAHis-
MaxKIF5C, pEYFP-KIF5C, pKIF5C-EYFP, pEYFP-KIF5C (1–335) (the KIF5C
motor domain) and pKIF5C(336–957)-EYFP (the KIF5C non-motor
domain) were all as previously described [2]. KIF5C was ampliﬁed from
pcDNAHisMaxKIF5C and subcloned into the NheI site of pECFP-C1 (BD
Biosciences, Clontech, CA) to generate pKIF5C-ECFP, i.e., KIF5C with an in
frameC-terminal ECFP tag.NucleocytoplasmicOGT (nOGT)wasampliﬁed
from pShuttle-OGT and subcloned into the BamHI/EcoRV sites of
pCMVTag4a to yield pCMVTag4a-nOGT that encodes nOGT with a
C-terminal FLAG tag. nOGT was ampliﬁed from pShuttle-OGT and
subcloned in frame into the HindIII/BamHI sites of pEYFP-C1 vector to
yield pEYPF-nOGT with an N-terminal EYFP tag. TRAK1 (OIP106) was
ampliﬁed frompCISTRAK1(formerly, pCISOIP106) and subcloned into the
XhoI/EcoRI sites ofpECFP-C1 togeneratepECFP-TRAK1.nOGTwasexcised
from pEYFP-nOGT using the HindIII/BamHI sites and subcloned in frame
into the same sites of pDsRed-Monomer-C1 (Clontech, CA) to generate
pDsRed-nOGT with the red ﬂuorescent protein tag at the nOGT
N-terminus. pCISTRAK2 (S562A)was generatedusing theQuikChangeTM
mutagenesis kit (Stratagene, La Jolla, CA). All constructs were veriﬁed by
DNA sequencing (MWG-Biotech AG, Germany). pDsRed1-Mito forvisualization of mitochondria was a gift from Professor R.J. Harvey,
University of London.
Afﬁnity-puriﬁed sheep anti-TRAK2 874–889 (formerly, anti-GRIF-1
874–889) and in house rabbit anti-FLAG antibodies were as described
[1,2]. Anti-TRAK1 antibodies were generated to the amino acid sequence,
Cys human TRAK1 (938–953) and afﬁnity-puriﬁed following standard
protocols. Sources of other antibodieswere: anti-His G, goat anti-rabbit Ig
Alexa ﬂuor 594 and anti-mouse Ig Alexa ﬂuor 594 (Invitrogen, Paisley,
UK); anti-c-Myc (Upstate, Charlottesville, VA); anti-kinesin superfamily
protein 5A (KIF5A) (AbCam, Cambridge, UK); anti-OGT polyclonal and
anti-FLAG M2 monoclonal antibodies (Sigma-Aldrich, Poole, UK); anti-
O-GlcNAc (Covance, Richmond, CA); anti-RHOT1 (Miro) antibodies
(Abnova, Taipei City). Afﬁnity-puriﬁed anti-Kv1.2 potassium channel
antibodies were a generous gift of Professor J. O. Dolly, Dublin, Ireland.
2.2. Mammalian cell transfection and preparation of detergent-solubilized
extracts of transfected cells
For immunoprecipitation assays, human embryonic kidney (HEK)
293 cells were transfected with either pCISTRAK2; pCISTRAK2 (S562A);
pCISTRAK2+pCMVTag4a-nOGT,pCMVTag4a-nOGT+pcDNAHisMaxKIF5Cor
pCISTRAK1/2+pCMVTag4a-nOGT+pcDNAHisMaxKIF5C by the calcium
phosphate method using 10 μg DNA for single transfections; a 1:1 ratio
with a total of 10 μg DNA per 250ml culture ﬂask for double transfections
and a1:1:1 ratiowith a total of 10 μgDNAper 250ml cultureﬂask for triple
transfections. Cells were harvested 24–48 h post-transfection and cell
homogenates were either analysed by immunoblotting or transfected cell
homogenateswere1% (v/v) TritonX-100detergent solubilizedandextracts
collected following centrifugation for 40min at 4 °C at 100000×g [1].
For confocal microscopy studies, HEK 293 cells or COS-7 cells were
plated onto poly-D-lysine (0.1 mg/ml)-coated coverslips and transfected
using the calcium phosphate method and plasmid DNA ratios as above.
Transfections using pDsRed1-Mito to visualize mitochondria in single
transfections used a ratio of 1 pDsRed1-Mito: 19 pECFP-TRAK1/2 or 19
pEYFP-nOGT for a total of 10 μg DNA. For double transfections, 10 μg DNA
were used at a ratio of 1 pDsRed-Mito: 9.5 pECFP-TRAK1/2+9.5
pEYFP-nOGT or 9.5 pECFP-TRAK1/2+9.5 pKIF5C-EYFP. For triple trans-
fections, for 10 μg DNA, the ratios were 1 pDsRed1-Mito: 6.3
pECFPTRAK1/2+6.3 pEYFP-nOGT+6.3 pcDNAHisMAXKIF5C.
2.3. Immunoblottting
Immunoblotting was performed as previously described [1].
Rabbit and mouse horseradish-linked secondary antibodies (Amer-
sham Pharmacia Biotech Ltd, Bucks., UK) were used at a ﬁnal dilution
of 1:2000 and immunoreactivities detected using the ECL western
blotting system. For detection of Miro, transfer was to polyvinylidene
ﬂuoride (PVDF) membranes, a dilution of 1:20000 of anti-mouse
horseradish-linked secondary antibodies was used and blots were
developed using the SuperSignal® West Femto ECL substrate (Perbio
Science UK Ltd., Northumberland, UK).
2.4. Immunoprecipitation assays
Immunoprecipitations from detergent-solubilized extracts of
transfected HEK 293 cells and native, adult mammalian brain tissues
were carried out as previously described [1,2].
2.5. Confocal microscopy and FRET efﬁciency determination
Transfected cells 20–40 h post-transfection were rinsed 3× with
ice-cold PBS followed by ﬁxation for 10 min with 4% (w/v) ice-cold
paraformaldehyde. Coverslips were rinsed 3× with PBS and mounted
onto a microscope slide using 10 μl mounting solution containing an
anti-fading agent (CitiFluor, Citiﬂuor Ltd., Leicester, UK). The cover-
slips were sealed and kept at−20 °C until analysis. Cells were imaged
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multitrack, sequential mode. EYFP was excited with λ=514 nm laser
line and emitted light was collected with a long pass ﬁlter LP530. ECFP
was excited at λ=458 nm and light collected with a band-pass ﬁlter
BP 475–525 nm. DsRed was excited with λ=545 nm and emitted
light collected with a long pass ﬁlter LP 560 nm. The absence of bleed-
through in co-transfected cells for all combinations was checked prior
to each experiment using the Meta software of the microscope. This
software enables decomposition of the mixed emission spectra (i.e.
generated from cells co-transfected with ECFP and EYFP or ECFP, EYFP
and DsRed) into the emission of each single ﬂuorescent dye expressed
in transfected cells, i.e., ECFP and EYFP or ECFP, EYFP and DsRed. This
decomposition step was performed according to reference spectra
generated from cells transfected with ECFP, EYFP or DsRed alone.
Images were analysed using Image Browser software (Zeiss) available
with the microscope. Mitochondrial distribution in transfected cells
was quantiﬁed in 2-D projections of z-stacks by measuring total pixel
intensity units for stained areas. They were subdivided into two
intracellular compartments. These were deﬁned as peripheral
mitochondria where staining was adjacent to the cell plasma
membrane and cytosolic for cytoplasmic mitochondria. Their relative
distribution was expressed as a percentage of the total staining.
For FRET analyses, again the Meta software mode of the LSM510
META Zeiss confocal microscope was used. FRET efﬁciency was
measured by acceptor photobleaching as before [2,18,19] That is, for
HEK 293 cells co-transfected with ECFP and EYFP tagged constructs,
cells were ﬁrstly imaged with the λ=458 nm laser to visualize
ECFP-tagged proteins. A deﬁned area of co-localization within one cell
was selected and EYFP was photobleached for~30 s using λ=514 nm
laser at full power. Cells were imaged post-photobleaching with the
λ=458 nm laser. FRET was measured as the increase of ECFP
ﬂuorescence after photobleaching where values were taken at
t=1.6 s prior to photobleaching and t=~32 s post-photobleaching
and were corrected for background ﬂuorescence (usually of the order
~10%) determined by imaging of untransfected HEK 293 cells. The
relative FRET efﬁciency was calculated by the following: (1- [pre-
bleached intensity of ECFP/post-bleached intensity of ECFP])×100%
[2]. For each FRET experiment, pseudo-FRET was always determinedFig. 1. KIF5A, TRAKs1/2 and nOGT co-immunoprecipitate from detergent extracts of rat brai
membranes, HEK 293 cells transfected with pCMVTag4a-nOGT or with pCMVTag4a (sham
anti-KIF5A or non-immune control Ig from detergent extracts of mammalian forebrain and i
The gel layout has the same format for each immunoprecipitation where: lane 1=detergen
pellet. Note that 6% of immune pellets were analysed for detection of immunoprecipitati
co-associating proteins. Immunoblots are representative of at least n=6 separate preparat
Kv1.2 immunoreactive bands. The positions of molecular weight standards (kDa) are on thby applying the photobleaching protocol to cells transfected with
pECFP alone. Pseudo-FRET values (typically ~2.9%) were always
subtracted from calculated FRET efﬁciencies of test samples. As a
further control, an area of the cell that was not photobleached was
also always analysed in parallel for FRET to ensure that determined
FRET efﬁciency values were not artefacts due to the photobleaching
protocol. A positive control, an ECFP-EYFP tandem construct linked by
two amino acids [20] and a negative control, co-transfection of the
separate clones, pECFP and pEYFP, were both used to validate the
system. For HEK 293 cells co-transfected with three constructs, i.e.,
ECFP, EYFP tagged constructs together with DsRed-nOGT or His-
KIF5C, cells expressing all three constructs were identiﬁed in the
single track modewith the red and green channels. Pairwise FRET was
carried out exactly as above with all appropriate controls. Note that
for these experiments, there was no overlap of the ECFP emission
spectrum with the absorption spectrum of DsRed ﬂuorophore.
3. Results
3.1. Immunoprecipitations from rat brain detergent extracts demonstrate
that KIF5A, TRAKs1/2 and nOGT form a ternary complex
TRAK2 co-immunoprecipitates with kinesin heavy chain from
detergent extracts of brain [1]. TRAK1 and TRAK2 also co-immunopre-
cipitate with OGT from detergent extracts of brain [15]. Here,
immunoprecipitations were carried out from detergent extracts of
brain to determine if a TRAK2/KIF5/OGT ternary complexwas present in
native tissue. The precipitating antibody for these experiments was
directed against KIF5Abecause in brain, TRAK2waspreviously shown to
associate predominantly with this kinesin-1 subtype [1]. Fig. 1
demonstrates the speciﬁcity of anti-OGT antibodies (Fig. 1A) and
further shows that TRAK2 (Mr=115 and 104 kDa) and OGT immunor-
eactivities (main immunoreactive species, Mr=110 kDa±3, n=3)
were both found in anti-KIF5A immune but not in control non-immune
pellets (Fig. 1B). An additional control found that anti-KIF5A antibodies
did not immunoprecipitate Kv1.2 potassium channels from detergent-
solubilized extracts of rat forebrain (Fig. 1B). These ﬁndings support the
existence of an in vivo TRAK2/KIF5/OGT ternary complex.n. A, characterization of the anti-OGT antibodies and is an immunoblot of rat forebrain
) probed with anti-OGT antibodies. B, immunoprecipitations were carried out with
mmune pellets analysed by immunoblotting using antibodies as shown in the abscissa.
t-solubilized forebrain homogenate; lane 2=non-immune pellet and lane 3=immune
ng antibody protein whereas 47% of immune pellets were analysed for detection of
ions of detergent extracts from adult rat brain.→ denotes KIF5A, TRAK1/2, nOGT and
e right.
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formation of the KIF5/TRAK2/OGT ternary complex
There are two forms of OGT, a mitochondrial (m) and a nucleocyto-
plasmic (n) variant. The TRAK1 and TRAK2 binding domain of OGT is
conserved between both forms mapping to mOGT-(51–100) and nOGT-
(167–283); [15,22; M. Beck, K. Pozo and F.A. Stephenson, unpublished
results). mOGT reportedly localizes within the mitochondrial inner
membrane [23] and would not therefore be accessible for binding to
soluble TRAK1 or TRAK2. It is thus more likely that TRAK1 and TRAK2
associate with nOGT. All following experiments used therefore the nOGT
variant. The kinesin was the prototypic KIF5C since earlier studies had
used this to investigate in vitro TRAK2/kinesin-1 interactions.
To determine the protein–protein interactions within the TRAK2/
KIF5/nOGT ternary complex an immunoprecipitation strategy employ-
ing over-expressed constructs in HEK 293 cells was used. Note that HEK
293 cells were utilized for these experiments since they generate
sufﬁcient material for immunoprecipitations. HEK 293 cells do express
endogenous nOGT and KIF5B but not TRAKs1 and 2 [1,3]. The strategy is
summarized in the schematic in Fig. 2.Fig. 2. Demonstration by immunoprecipitation that TRAK2 forms a ternary complexwith KIF5C
summarizing results. B–E, HEK 293 cells were transfected in parallel with either pCMVTag4a-
(pCISTRAK2+pCMVTag4a-nOGT+pcDNAHisMaxKIF5C), detergent extracts of cell homogena
afﬁnity-puriﬁed anti-FLAG antibodies or non-immune Ig and immune pellets analysed by imm
antibodies by probing the immune pellet with both polyclonal and monoclonal anti-FLAG ant
presence of TRAK2, KIF5C immunoreactivity is now found in anti-FLAG (nOGT) immune p
1=detergent-solubilized transfectedHEK 293 cell homogenate; lane 2=non-immunepellet a
immunoprecipitating antibody protein whereas 90% of immune pellets were analysed for
immunoprecipitations from n=4 independent transfections.→ denotes KIF5A, TRAK1/2 and n
(kDa) are on the right.Firstly, HEK 293 cells were transfected with pCMVTag4a-nOGT and
immunoprecipitations carriedoutwithpolyclonal anti-FLAGantibodies.
Immune pellets were probed with both polyclonal and commercial
monoclonal (M2 FLAG) antibodies to verify the speciﬁcity of the
immunoreactive bands precipitated by polyclonal anti-FLAG antibodies
(Fig. 2B). Then, cells were co-transfected with pCMVTag4a-nOGT and
pCISTRAK2 and immunoprecipitations carried out with anti-FLAG
antibodies. Anti-FLAG (i.e. nOGT; Mr=115±1, n=12) and TRAK2
immunoreactivitieswere both found in immunebut not in control, non-
immunepellets thereby replicating earlierﬁndings that nOGTassociates
withTRAK2 (Fig. 2C) [15]. ForpcDNAHisMaxKIF5C+pCMVTag4a-nOGT
co-transfections, following immunoprecipitation with anti-FLAG anti-
bodies, anti-FLAG immunoreactivity was found in immune but not in
control non-immune pellets showing that nOGT was speciﬁcally
immunoprecipitated (Fig. 2D). But, although KIF5C was expressed
robustly in detergent extracts, anti-His immunoreactivity (i.e. KIF5C)
wasnot detected in either anti-FLAGor control immunepellets showing
that nOGT does not co-immunoprecipitate with KIF5C. In triple
transfections where TRAK2, KIF5C and nOGT were all co-expressed in
HEK 293 cells and immunoprecipitations carried out using anti-FLAGandnOGT inHEK293 cells. A, a schematic diagramdepicting the experimental strategy and
nOGT; (pCISTRAK2+pCMVTag4a-nOGT); (pCMVTag4a-nOGT+pcDNAHisMaxKIF5C) or
tes prepared 48 h post-transfection, immunoprecipitation assays carried out using either
unoblotting using antibodies as shown in the abscissa. B, speciﬁcity of in house anti-FLAG
ibodies. C, nOGT associates with TRAK2. D, nOGT does not associate with KIF5C. E, in the
ellets. The gel layout has the same format for each immunoprecipitation where: lane
nd lane 3=immunepellet. Note that 10% of immune pellets were analysed for detection of
detection of co-associating proteins. Immunoblots are representative of at least n=4
OGT immunoreactive bands as appropriate. The positions of molecular weight standards
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control pellets. This demonstrated the formation of a TRAK2/KIF5C/
nOGT ternary complex and that it is the presence of TRAK2 that
mediates the association of the three proteins (Fig. 2E).
3.3. TRAK2 is a substrate for OGT; demonstration of modiﬁcation of
TRAK2 (S562) by GlcNAc
Iyer et al. [15] reported that TRAK2 (and TRAK1) were modiﬁed by
GlcNAc following their respective over-expression in cells. This was
carried out using anti-O-GlcNAc antibodies to probe immunoprecipi-
tated proteins with speciﬁcity being demonstrated by competing out
the immune signal with GlcNAc. A different approach was utilized
here. The YingOYang neural network that predicts sites of O-βGlcNAc
attachment in eukaryotic protein sequences was used to identify
potential O-glycosylation sites in TRAK2 (http://www.cbs.dtu.dk/
services/YinOYang/). The site with the highest score, i.e., TRAK2 S562,
was mutated to TRAK2 (S562A) to remove the putative serine
O-glycoyslation site. Wild-type pCISTRAK2 and pCISTRAK2 (S562A)
were each expressed in parallel in HEK 293 cells, immunoprecipita-
tions carried out and immune pellets analysed by both anti-TRAK2
(874–889) and anti-O-GlcNAc antibodies, i.e., antibodies that recog-
nize serine/threonine residues modiﬁed by GlcNAc (Fig. 3). No
signiﬁcant differences were found between TRAK2 and TRAK2
(S562A) total expression or between anti-TRAK2 (874–889) immu-
noreactivities in the respective immune pellets. However, a 73±3.2%
( n=3) decrease in anti-O-GlcNAc immunoreactivity was observed in
TRAK2 (S562A) immunoprecipitates (Fig. 3). These ﬁndings conﬁrm
TRAK2 as a substrate for OGT but they extend earlier studies to
identify S562 as a site of O-GlcNAc modiﬁcation.
3.4. Confocal microscopy imaging and FRET studies of KIF5C/TRAK1,
KIF5C/TRAK1//nOGT and KIF5C/TRAK2/nOGT interactions
We previously showed using confocal microscopy imaging in
COS-7 cells co-transfected with TRAK2 (GRIF-1) and KIF5C, that
TRAK2 recruitedmitochondria to exogenous kinesin heavy chains and
that all three, i.e., TRAK2, KIF5C and mitochondria, were co-localizedFig. 3. TRAK2 is a substrate for OGT; demonstration of modiﬁcation of TRAK2 (S562) by Gl
(S562A), detergent extracts of cell homogenates prepared 48 h post-transfection, immunop
and immune pellets analysed by immunoblotting using antibodies as shown in the absciss
anti-O-GlcNAc antibodies. C, a histogram summarizing the quantitative immunoblots in
immunoprecipitation where: lanes 1 and 3=non-immune pellet; lanes 2 and 4=immune
anti-TRAK2 (874–889) antibodies whereas 90% of immune pellets were analysed for detec
representative of n=2 immunoprecipitations from n=2 independent transfections.→ de
standards (kDa) are on the right.at the end of cellular extensions [2]. FRET analyses demonstrated that
TRAK2 associated directly with the non-motor domain of KIF5C
suggesting that TRAK2 serves as an adaptor protein linking mito-
chondria to kinesin [2]. Here we used the same imaging strategy to
study KIF/TRAK/nOGT interactions. Note that COS-7 cells were utilized
for co-distribution studies since they have a larger cytoplasm
compared to HEK 293 cells thus giving higher subcellular resolution.
All FRET studies however were carried out in HEK 293 cells. This was
because FRET efﬁciencies weremeasured by acceptor photobleaching.
In COS-7 cells, the expression level of the ﬂuorescent constructs was
relatively low and exposure to the appropriate laser for cell imaging
resulted in the photobleaching of either EYFP or ECFP thus preventing
the measurement of FRET. In HEK 293 cells, the expression of
constructs was higher due to both higher transfection efﬁciencies and
greater protein expression thus circumventing problems due to
photobleaching [2]. Similar subcellular distribution proﬁles were
found for the expression of all single, pairwise and triple TRAK/
kinesin/nOGT combinations for both COS-7 and HEK 293 cells. COS-7
cells, like HEK 293 cells do not express endogenous TRAK1 and
TRAK2; they do express kinesin and nOGT.
3.4.1. TRAK1 recruits mitochondria to kinesin heavy chains via its direct
interaction with the KIF5C non-motor domain
TRAK2 and TRAK1 belong to the same coiled-coil gene family and
although it may be assumed that they behave similarly with respect to
TRAK2 in FRET studies, it is still necessary to prove that this is the case.
An N-terminal ECFP-TRAK1 construct was therefore generated and
expressed either alone or with KIF5C-EYFP in COS-7 cells and
mitochondrial distribution in these cells imaged. Representative results
are shown in Fig. 4B and C. ECFP-TRAK1 when expressed alone was
localized in the cell cytoplasm being particularly enriched in areas
adjacent to the cell nucleus (Fig. 4B). Mitochondria co-distributed with
ECFP-TRAK1 similarly to previous observations for TRAK2 (compare
Fig. 4B with the control, Fig. 4A) [2]. Co-expression of ECFP-TRAK1with
KIF5C-EYFP resulted in redistribution of TRAK1 such that it now
predominantly co-distributed with KIF5C-EYFP at the tips of cellular
processes. Mitochondria were also now redistributed; the majority co-
localized with ECFP-TRAK1 and KIF5C-EYFP in these regions (Fig. 4C).cNAc. HEK 293 cells were transfected in parallel with either pCISTRAK2 or pCISTRAK2
recipitation assays carried out using anti-TRAK2 (8–633) antibodies or non-immune Ig
a. A, immunoblotting with anti-TRAK2 (874–889) antibodies. B, immunoblotting with
A and B. Values are means±SEM. The gel layout has the same format for each
pellet. Note that 10% of immune pellets were analysed for detection of TRAK2 using
tion of O-GlcNAc modiﬁed proteins using anti-O-GlcNAc antibodies. Immunoblots are
notes TRAK2 and O-GlcNAc immunoreactive bands. The positions of molecular weight
Fig. 4. Confocal microscopy imaging and FRET studies of ECFP-TRAK1 and EYFP-KIF5C association in COS-7 cells. A–C, ECFP-TRAK1 and/or EYFP-KIF5C and/or DsRed1-Mito were
co-expressed in COS-7 cells, cells were ﬁxed 24–40 h post-transfection and imaged by confocal microscopy. As indicated on each image, red=mitochondria; blue=TRAK1 and
yellow=KIF5C; merge shows respective merged images for each panel and pixel intensity proﬁles are seen in adjacent line scans. A, DsRed1-Mito transfected cells.
B, co-transfections with ECFP-TRAK1+DsRed1-Mito. C, co-transfections with ECFP-TRAK1, EYPF-KIF5C and DsRed1-Mito. All images are a single confocal section of a selected cell;
outline denotes images with saturated ﬂuorescence intensity to show complete cell outlines. Images are representative of at least n=14 cells from at least n=4 independent
transfections. Scale bars are 10 μm. D, ECFP-TRAK1 and either EYFP-KIF5C, KIF5C-EYFP, EYFP-KIF5C (1–335), (motor domain) or KIF5C (336–957)-EYFP (non-motor domain) were
co-expressed in HEK 293 cells in parallel with the experimental positive control, ECFP-TRAK2 and KIF5C-EYFP, and FRET efﬁciencies by acceptor photobleaching were measured. The
negative control is HEK 293 cells transfected with pECFP and pEYFP; the positive control is HEK 293 cells transfected with the pECFP-EYFP tandem construct. The results are means±
SEM for at least n=20 individual cells from n=3 independent transfections for each pairwise combination with at least 6 individual cells per transfection. Each FRET efﬁciency was
compared to FRET efﬁciencies obtained for the negative control using an unpaired Student t-test. ***, pb0.001; *, pb0.05.
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and COS-7 cells [2,8], for TRAK1 expressed alone in HEK 293 or COS-7
cells [2,21] or, with kinesin in COS-7 cells [8].
Pairwise FRET measurements were carried out to determine if
TRAK1 associated directly with KIF5C (Fig. 4D). For these experiments,
ECFP-TRAK2/EYFP-KIF5C and ECFP-TRAK1/EYFP-KIF5C FRET measure-
ments were always carried out in parallel. As for ECFP-TRAK2, FRETwas
found with the C-terminal tagged, full length KIF5C-EYFP construct
only; no FRET signal was detected between N-terminal EYFP-KIF5C and
ECFP-TRAK1 constructs (Fig. 4D). There was no detectable FRET
between ECFP-TRAK1 and the kinesin motor domain, EYFP-KIF5C (1–
335). In contrast, the FRET efﬁciency between ECFP-TRAK1 and KIF5C
(336–957)-EYFP, i.e., the KIF5C non-motor domain, was not signiﬁ-
cantly different to that foundwith full length KIF5C-EYFP indicating that
like TRAK2, TRAK1 interacts directly with KIF5C non-motor domains.
Interestingly, the FRET efﬁciency measured between ECFP-TRAK1/
KIF5C-EYFP was signiﬁcantly lower than that for ECFP-TRAK2/KIF5C-
EYFP; values were 8.7±0.4% (n=64) compared to 10.4±0.5%
(n=20), respectively (pb0.05). TRAK1 is ~40 amino acids longerthan TRAK2 and the decreased FRET efﬁciency may reﬂect subtle
differences between interactions of TRAK1 and TRAK2with this kinesin.
FRET values for the ECFP-EYFP tandem construct used as the positive
controlwere 22.6±0.8% (n=54) and for the pECFP and pEYFPnegative
control, 3.1±0.2% (n=49) (Fig. 4D).
3.4.2. Confocalmicroscopy imaging and FRET studies of KIF5C/TRAK1/nOGT
and KIF5C/TRAK2nOGT protein–protein interactions
EYFP-nOGT expressed alone in COS-7 cells had a diffuse, cytoplasmic
distribution with some nOGT also present at cell membranes (Figs. 5A
and 6A). When co-expressed with ECFP-TRAK1 or ECFP-TRAK2, the
distribution pattern changed such that EYFP ﬂuorescence was mostly
localized close to cell nuclei where it co-distributed with TRAK2 or
TRAK1 (Figs. 5B and 6B). In some cells, low amounts of EYFP-nOGTwere
also evident at the tips of processes where it co-localized with either
TRAK2 or TRAK1 (e.g. Fig. 5B). TRAK1 and TRAK2 are known to associate
with endogenous KIF5B in HEK 293 cells which may explain these
observations [2,21]. Co-expression of EYFP-nOGT with ECFP-KIF5C did
not result in a change in cellular distribution of EYFP ﬂuorescence. No
Fig. 5. Confocal microscopy imaging and FRET studies of ECFP-TRAK2, EYFP-KIF5C and EYPF-nOGT association in COS-7 cells. A–D, COS-7 cells were transfected with either pEYFP-nOGT
(A); pEYFP-nOGT+pECFP-TRAK2 (B); pEYFP-nOGT+pKIF5C-ECFP (C) or pEYFP-nOGT+pKIF5C-ECFP+pCISTRAK2 (D), ﬁxed 24–40 h post-transfection and imaged by confocal
microscopy. The ﬂuorophore is indicated on each image and is: yellow=OGT; blue=TRAK2 or KIF5C; red=TRAK2;merge shows respectivemerged images for each panel and the pixel
intensityproﬁles are seen inadjacent linescans.All imagesare a single confocal sectionof a selectedcell; outlinedenotes imageswith saturatedﬂuorescence intensity to showcomplete cell
outline. Images are representative of at least n=14 cells from at least n=4 independent transfections. Scale bars are 10 μm. E, ECFP-TRAK2 and either (KIF5C-EYFP), (EYFP-nOGT),
(KIF5C-EYFP+DsRed-nOGT), (EYFP-nOGT+His-KIF5C) or (KIF5C-ECFP+EYFP-nOGT+TRAK2) were co-expressed in HEK 293 cells and FRET efﬁciencies were measured by acceptor
photobleaching. The negative control is HEK 293 cells transfected with pECFP and pEYFP and the positive control is HEK 293 cells transfected with the pECFP-EYFP tandem construct.
Results aremeans±SEMfor at leastn=27 individual cells fromn=3 independent transfections for eachpairwise combinationwithapproximately9 individual cells per transfection. Each
FRET efﬁciency was compared to the FRET efﬁciency obtained for the negative control using an unpaired Student t-test. ****, pb0.0001; **, pb0.01.
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6C). Co-expression of EYFP-nOGT, ECFP-KIF5C and TRAK1 or TRAK2
resulted in co-localization of all three proteins. This co-distribution was
particularly evident at the tips of COS-7 cell processes where an
enrichment of all three proteins was observed (Figs. 5D and 6D).
Pairwise FRET measurements were also carried out to determine if
nOGT associated directly with TRAK1, TRAK2 or KIF5C and further, if
association of nOGT with TRAK1 or TRAK2 had an effect on TRAK2/
KIF5C association. For these experiments, all FRET measurementsincluding the ECFP-EYFP tandem positive control and pECFP and pEYFP
negative control were always carried out in parallel. Determinations of FRET
efﬁciency values were carried out on areas of co-localization at tips of cellular
processes. In triple transfections, the presence of nOGT in [EYFP-KIF5C+ECFP-
TRAK1/2+nOGT] was veriﬁed by the use of a DsRed-nOGT construct; the
presence of His-KIF5C in [ECFP-TRAK1/2+EYFP-nOGT+KIF5C] or TRAK1/2 in
[ECFP-KIF5C+EYFP-nOGT] co-transfections was evident from the distribution
of nOGT, i.e., it is only co-localized and enriched at the tips of processes
in the presence of bothHis-KIF5C and TRAK1/2. The results obtained are
Fig. 6. Confocal microscopy imaging and FRET studies of ECFP-TRAK1, EYFP-KIF5C and EYPF-nOGT association in COS-7 cells. A–D, COS-7 cells were transfected with either pEYFP-nOGT
(A); pEYFP-nOGT+pECFP-TRAK1 (B); pEYFP-nOGT+pKIF5C-ECFP (C) or pEYFP-nOGT+pKIF5C-ECFP+pCISTRAK1 (D), ﬁxed 24–40 h post-transfection and imaged by confocal
microscopy. The ﬂuorophore is indicated on each image and is: yellow=OGT; blue=TRAK1 or KIF5C; red=TRAK1; merge shows the respective merged images for each panel and the
pixel intensity proﬁles are seen in adjacent line scans. All images are a single confocal section of a selected cell; outline denotes images with saturated ﬂuorescence intensity to show
complete cell outlines. Images are representative of at least n=14 cells from at least n=4 independent transfections. Scale bars are 10 μm. E, ECFP-TRAK1 and either (KIF5C-EYFP),
(EYFP-nOGT), (KIF5C-EYFP+DsRed-nOGT), (EYFP-nOGT+His-KIF5C) or, (KIF5C-ECFP+EYFP-nOGT+TRAK1) were co-expressed in HEK 293 cells and FRET efﬁciencies by acceptor
photobleachingweremeasured. The negative control is HEK 293 cells transfectedwith pECFP and pEYFP and the positive control is HEK 293 cells transfectedwith the pECFP-EYFP tandem
construct. Results are means±SEM for at least n=20 individual cells from n=3 independent transfections for each pairwise combination with approximately 6 individual cells per
transfection. Each FRET efﬁciency was compared to the FRET efﬁciency obtained for the negative control using an unpaired Student t-test. ****, pb0.0001; *, pb0.05.
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obtained between EYFP-nOGT and either ECFP-TRAK1 or ECFP-TRAK2with
efﬁciencies of 7.3±0.4% (n=27) and 8.7±0.5% (n=38), respectively.
There was no signiﬁcant FRET when EYFP-nOGT was expressed with
ECFP-KIF5C in the presence of TRAK1 or TRAK2; values were 2.3±0.3%
(n=10) and 2.5±0.4% (n=11) compared to 2.4±0.3% (n=35) for
negative controls. In the presence of DsRed-nOGT, the FRET signal between
ECFP-TRAK2 and EYFP-KIF5C was reduced to 6.8±0.6% (n=27), pb0.01.
The FRET signal for ECFP-TRAK1 and EYFP-KIF5C in the presence ofDsRed-nOGT was not signiﬁcantly different to values for ECFP-TRAK1 and
EYFP-KIF5C alone, i.e., 7.8±0.6% versus 7.7±0.5%. In the presence of
His-KIF5C, there was no signiﬁcant difference in FRET efﬁciency for
ECFP-TRAK2 and EYFP-nOGT but for ECFP-TRAK1 and EYFP-nOGT, a small
but signiﬁcant reduction was found with values being, 6.1±0.4% (n=22)
for [ECFP-TRAK1+ EYFP-nOGT+His-KIF5C] and 7.3±0.4% (n=27) for
[ECFP-TRAK1+EYFP-nOGT], pb0.05. Thus the FRET measurements con-
solidate the immunoprecipitations and confocal microscopy imaging
observations in that they infer that nOGT associates directly with TRAK1
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measured for the two ternary complexes suggesting possible conforma-
tional distinctions in protein–protein association.
3.5. Miro is a component of TRAK1/KIF5C/nOGT ternary complexes:
Demonstration by immunoprecipitation
To determine if Miro, a mitochondrial acceptor for TRAKs, was a
component of KIF5C/TRAK1/nOGT and KIF5C/TRAK2/nOGT ternary
complexes, an immunoprecipitation strategy similar to that described
in Fig. 2 was employed. FLAG-tagged nOGT, His-KIF5C and TRAK1 or
TRAK2 were all co-expressed in HEK 293 cells, immunoprecipitations
carried out using anti-FLAG antibodies (Fig. 7A), or non-immune IgG
and immune pellets analysed by immunoblotting using anti-FLAG,
anti-TRAK2 (874–889), anti-HisG or anti-RHOT1 (Miro) antibodies.
All four proteins, including Miro with Mr=78±2 (n=10), were
found in immune but not in non-immune pellets (Fig. 7A). Since
endogenous Miro was not co-immunoprecipitated with His-KIF5C in
His-KIF5C transfections (Fig. 7E) nor was it co-immunoprecipitated
with nOGT or KIF5C in [nOGT+KIF5C] transfections (Fig. 7D), these
observations are consistent with formation of ternary complexes,
TRAK(1/2)/nOGT/Miro and KIF5C/TRAK(1/2)nOGT or alternatively, an
KIF5C/TRAK(1/2)/nOGT/Miro quaternary complex. To distinguish
between these possibilities, immunoprecipitations were carried outFig. 7. Demonstration by immunoprecipitation that endogenous Miro associates with the T
pcDNAHisMaxKIF5Calone;pcDNAHisMaxKIF5C+pCMVTag4a-nOGTor,withpcDNAHisMaxKI
were prepared 48 h post-transfection, immunoprecipitation assays carried out using either afﬁ
pelletswere analysedby immunoblottingusing antibodies as shown in theabscissa. The gel layo
homogenate; lane 2=non-immune pellet and lane 3=immune pellet. In E and F, immunopre
immune pellets were analysed for detection of immunoprecipitating antibody protein where
schematic diagramdepicting the experimental strategy and summarizing results. The positions
least n=3 immunoprecipitations from n=3 independent transfections.from HEK 293 cells transfected with FLAG-tagged nOGT, His-KIF5C
and TRAK1 or TRAK2 but this time, immunoprecipitations were
carried out with anti-His rather than anti-FLAG antibodies (Fig. 7B and
C). As for immunoprecipitation with anti-FLAG antibodies, all four
proteins were detected in immune but not in non-immune pellets
thus providing evidence for the KIF5C/TRAK(1/2)/nOGT/Miro quater-
nary model (Fig. 7).
Note that all immunoprecipitations were carried out in the
absence of Ca2+. It was recently reported that in the presence of
2 mM Ca2+, the motor domain of kinesin associated directly with
Miro resulting in the immobilization of mitochondria [24]. Apparently
contradictory results were published simultaneously by MacAskill et
al. [25] who demonstrated that formation of a Miro/KIF5 complex is
inhibited by Ca2+. To try to resolve this issue, His-KIF5C was
expressed in HEK 293. In agreement with [24], Miro was now
detected in the immune pellets (Fig. 7F).
3.6. Mitochondrial distribution in COS-7 cells transfected with nOGT,
TRAK1, TRAK2 and KIF5C constructs
In the presence of TRAK1 or TRAK2 and kinesin heavy chains, a
redistribution of mitochondria is observed such that they become
enriched at the tips of cellular processes where they co-localise with
both TRAK1 or TRAK2 and kinesin [2,8; Fig. 4]. Both TRAK1 and TRAK2RAK/KIF/nOGT ternary complex. HEK 293 cells were transfected in parallel with either
F5C+pCMVTag4a-nOGT+pCISTRAK1/2as shown.Detergent extracts of cell homogenates
nity-puriﬁed anti-FLAG (A and D); anti-His G (B, C, E and F) or non-immune Ig. Immune
ut is the same for all sampleswhere lane1=detergent-solubilized transfectedHEK293 cell
cipitations were carried out in the absence (E) and presence (F) of Ca2+. Note that 10% of
as 90% of immune pellets were analysed for detection of co-associating proteins. G is a
ofmolecularweight standards (kDa) are on the right. Immunoblots are representative of at
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Miro [8, 11 and see also Fig. 7] and importantly, TRAK2 was shown to
participate in mitochondrial transport in processes of hippocampal
neurones [10]. It was thus of interest to determine by confocal
microscopy imaging if co-association of TRAK1 and TRAK2 with nOGT
had any effect on the TRAK1/2/KIF5-induced redistribution of
mitochondria and thereby mitochondrial trafﬁcking.
COS-7 cells were transfected with [nOGT+pDsRed1-Mito]; [TRAK1
or TRAK2+nOGT+pDsRed1-Mito] and [KIF5C+TRAK1 or TRAK2+
nOGT+pDsRed1-Mito] and mitochondrial distribution analysed by
confocal microscopy imaging (Fig. 8). Expression of EYFP-nOGT in
COS-7 cells had no effect on mitochondrial distribution. Mitochondria
were uniformally distributed throughout the cell cytoplasm (Fig. 8A). Co-
expression of either ECFP-TRAK1 or ECFP-TRAK2 with EYFP-nOGT
resulted in redistribution of mitochondria so that there was an observed
collapse of the mitochondrial network with localization now found in
areas in the vicinity of the cell nuclei where they co-localized with ECFP-
TRAK1 or ECFP-TRAK2 and EYFP-nOGT (Fig. 8B and C and see also Figs. 5B
and 6B). In the triple ECFP-TRAK1 (or ECFP-TRAK2), EYFP-nOGT+His-
KIF5C transfections,mitochondrial distributionwasonlyanalysed in those
cells that showed characteristics of His-KIF5C transfected cells, i.e., EYFP
and ECFPﬂuorescencewas co-localized and enriched at the tips of cellular
extensions. This phenotypewasevident in themajority (i.e. estimated60–
70%) of transfected cells. In representative images, although co-
localization of mitochondria with ECFP-TRAK1/2 and EYFP-nOGT was
observed at these tips, it was evident that a signiﬁcant proportion of
mitochondria remained within the cell cytoplasm. These mitochondria
were observed in all cells co-transfected with [ECFP-TRAK2 or ECFP-
TRAK1, EYFP-nOGT and His-KIF5C] (Fig. 8E and G). Although some
mitochondria do remain in the cell cytoplasm in some cells co-transfected
with ECFP-TRAK1 or TRAK2 and EYFP-KIF5C (e.g. Figs. 4C and 8D and F),
theappearanceof thesecytoplasmicmitochondria in the triple transfected
cellswasmarkedly different to that observed for double TRAK1 or TRAK2/
KIF5C distributions. Firstly, theywere not randomly distributed as imaged
in pDsRed-Mito transfected cells (Fig. 4A). Instead, they appeared as
distinct mitochondrial clusters (Fig. 8E). This contrasts with the large
aggregates observed in TRAK1/2 single or TRAK1/2/KIF5C double
transfections. In some instances, themitochondria appeared to be aligned
and reminiscent of the “string of pearls”neuronal distribution reported by
Guo et al. [26] in the Drosophila, dmiro mitochondrial trafﬁcking mutant.
Secondly, the number ofmitochondrial clusterswas higher and present in
all triple transfections. The cytoplasmic mitochondria of transfected cells in
which KIF5C was clearly expressed, were scored for their co-distribution with
TRAK1or TRAK2 alone; nOGTaloneor (TRAK1+nOGT) and (TRAK2+nOGT)
combined. The results are summarized in the Table in Fig. 8. Cytoplasmic
mitochondria showed co-localization with TRAK1/2 and nOGT suggesting
possible dissociation of TRAK1/2 from the motor protein or alternatively,
arrested movement.4. Discussion
In this paper, we have presented further information on the
molecular constituents of the TRAK/kinesin mitochondrial trafﬁcking
complex. We had previously demonstrated by immunoprecipitation
that TRAK2 associated with kinesin 5A (KIF5A) in the brain. Using a
combination of FRET and yeast two-hybrid interaction assays, we
showed that this interactionwasdirect and further, that itwasmediated
via the C-terminal cargo binding domain of kinesin and the ﬁrst
predicted coil domain of TRAK2. Here, we have extended these studies
to demonstrate that TRAK1 behaves similarly to TRAK2, that the post-
translational enzyme, nOGT, is an integral component of at least a
population of TRAK/kinesin complexes and TRAK/kinesin/cargo traf-
ﬁcking composites; that TRAK2 is a substrate for nOGT and TRAK2 S562
is identiﬁed as a residue modiﬁed by GlcNAc. Finally, we report that,
Miro, the putativemitochondrial acceptor for TRAK1/2, in the absence ofCa2+associates indirectlywithKIF5Cvia the intermediary TRAKadaptor
proteins.
OGT is known to associate in vivo and in vitro with TRAK1 and
TRAK2, but it was not known if it associated with binary TRAK/kinesin
protein complexes. An immunoprecipitation strategy was used to
demonstrate that indeed nOGT does co-associate with TRAK2/KIF5C.
This ﬁnding was substantiated by confocal imaging of COS-7 cells
transfected with relevant clones. That is, when expressed alone,
EYFP-nOGT was distributed widely throughout the cell cytoplasm but
when co-expressed with either TRAK1 or TRAK2, its distribution was
changed such that it now co-localized with aggregated mitochondria
and with TRAK1 or TRAK2, close to cell nuclei. In the presence of KIF5C
and TRAK1 or TRAK2, EYFP-nOGT was trafﬁcked to the tips of cellular
processes where it co-localized with both exogenous proteins and also,
the trafﬁcked mitochondria. However, despite the clear demonstration
of the co-distribution of the three proteins and their co-association, no
FRET signal was detected between nOGT and KIF5C implying that either
the distance between the two proteins within the ternary complex is
greater than the minimum required to enable detection of FRET i.e.,
N~5 nm or alternatively, that the angle between the ECFP and EYFP
ﬂuorophores is unfavourable for detection of FRET [27]. The FRET
efﬁciency was also measured in triple transfections to determine if the
presence of nOGT or KIF5C affected association between TRAK1/2 and
KIF5C or TRAK1/2 and nOGT respectively. For all combinations, FRET
was detectable but the presence of DsRed-nOGT decreased signiﬁcantly
the FRET signal between ECFP-TRAK2and EYPF-KIF5C; a smaller but still
signiﬁcant change was found for the effect of KIF5C on the FRET signal
between EYFP-nOGT and ECFP-TRAK1. These ﬁndings suggest that
ternary complex formation may elicit a subtle change in protein
conformation that is detectable by decreased FRET efﬁciencies.
Since nOGT is a post-translational modiﬁcation enzyme, one may
speculate that its role in the ternary moiety is to regulate the
trafﬁcking complex. Thismay be by controlling association of TRAK1/2
with kinesin; by regulating binding of the cargo to TRAK1/2 or by
controlling the release of the cargo once delivered to the appropriate
destination within the cell. The mechanism may therefore involve
O-glycosylation of kinesin, of TRAK1/2 (both known to be substrates
for OGT and O-glycosylated in vivo [15], or of the deﬁned cargo. Here
we have conﬁrmed that TRAK2 is O-glycosylated and we have
identiﬁed at least one site at which this occurs. However, mutation of
this site did not impair mitochondrial redistribution (results not
shown). Further, it is evident that multiple sites are glycosylated since
TRAK2 (S562A) was still recognized by anti-GlcNAc antibodies thus
regulation may involve other potential sites of GlcNAc modiﬁcation
and requires an in depth systematic study.
Alternatively, since there is a reciprocal relationship between
O-glycosylation and phosphorylation [28], it may be that it is the
balance between these two modiﬁcations that is important for such a
regulatory mechanism. It was recently demonstrated that phosphor-
ylation of S1029 of kinesin, KIF17, by calcium-calmodulin-dependent
protein kinase II (CaMKII) was the molecular switch that controlled
interaction between KIF17 and the scaffold protein, Mint1 [29].
Phosphorylation of this residue disrupted KIF17-Mint1 association
resulting in release of the transported cargo which in this case was
N-methyl-D-aspartate receptor NR2B subunit-containing vesicles
[29]. Other examples of regulation by phosphorylation include the
CaMKII modulation of myosin V-cargo association, c-Jun interacting
kinase regulation of kinesin-1 linker proteins (JNK-interacting
proteins or JIPs) and the delivery of rhodopsin by phosphorylation
of dynein light chain (reviewed in [30]). Interestingly, in skeletal
muscle, myosin heavy and light chains and also actin were shown to
be O-glycosylated leading to the proposal that GlcNAc modiﬁcation of
contractile proteins modulates muscle contraction [31]. In fact,
although it was shown that Miro was able to form a quaternary
complex with TRAK2, KIF5C and nOGT, when all three proteins were
co-expressed in COS-7 cells, it was evident that a signiﬁcant number
Fig. 8. Confocal microscopy imaging of mitochondrial distribution in COS-7 cells transfected with nOGT, TRAK1, TRAK2 and KIF5C constructs. COS-7 cells were transfected with either pEYFP-nOGT+pDsRed1-Mito (A); pEYFP-nOGT+pECFP-
TRAK1+pDsRed1-Mito (B); pEYFP-nOGT+pECFP-TRAK2+pDsRed1-Mito (C); pECFP-TRAK1+pKIF5C-EYFP+pDsRed1-Mito (D); pECFP-TRAK1+pEYFP-nOGT+pcDNAHisMaxKIF5C+pDsRed1-Mito (E); pECFP-TRAK2+pKIF5C-EYFP+
pDsRed1-Mito (F); pECFP-TRAK2+pEYFP-nOGT+pcDNAHisMaxKIF5C+pDsRed1-Mito (G), ﬁxed 24–40 h post-transfection and imaged by confocal microscopy. Outline refers to images with saturated ﬂuorescence intensity to show
complete cell outlines. The ﬂuorophore is indicated on each image and is: yellow=OGT or KIF5C; blue=TRAK1 and TRAK2 and red=mitochondria; merge shows respective merged images for each panel. In A–C, images are a single confocal
section of a selected cell. D–G, 2-D projections of z-stacks. Scale bars are 10 μm. H, relative distribution of mitochondria in the cell periphery and cell cytosol quantiﬁed as in [2]. Images are representative of at least n=20 cells from at least
n=3 independent transfections. *** pb0.001. I, COS-7 cells were co-transfected with [pECFP-TRAK1+pEYFP-nOGT+pDsRed1-Mito+pcDNAHisMaxKIF5C] or [pECFP-TRAK2+pEYFP-nOGT+pDsRed1-Mito+cDNAHisMaxKIF5C]. Cells
were ﬁxed 24–40 h post-transfection and imaged by confocal microscopy. Cells that showed the characteristics of His-KIF5C transfected cells, i.e., EYFP and ECFP ﬂuorescence was co-localized and enriched at the tips of cellular extensions,
were identiﬁed. In these cells, mitochondria were enriched at the ends of cell processes but they were also clustered in the cell cytoplasm. Cells were scored qualitatively in 2D projections of z-stacks with respect to the co-distribution of the
clustered, cytoplasmic mitochondria with TRAK1, TRAK2 or nOGT alone; with nOGT+TRAK1 or nOGT+TRAK2 or for no observed co-distribution. For TRAK1 transfectants, n=16 cells and for TRAK2, n=16 cells were analysed.
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cells expressing only TRAK1/2 and KIF5C where the majority of
mitochondria were visualized, concentrated at the ends of processes
(e.g. Figs. 4 and 8D and F and see also, [2]). Thus it may be that in the
presence of exogenous nOGT compared to assumed lower concentra-
tions of endogenous nOGT, the equilibrium is shifted towards an
increased O-glycosylation state of KIF5, TRAK2 or the cargo (i.e. Miro)
resulting overall in a disruption ofmitochondrial trafﬁcking processes.
Alternatively, the binding site for KIF5C maps to TRAK2 (128–293)
whereas nOGT maps to residues TRAK1 (639–859) [22] which
corresponds by sequence alignment to TRAK2 (622–846). The binding
site for Miro maps to TRAK2 (476–700) [10]. There is therefore,
potential for overlapping binding domains within TRAK2 for Miro and
OGT. However, since the mitochondria not trafﬁcked by KIF5C still
aggregate it would be reasonable to conclude that it is the association
between KIF5C and TRAK1/2 that is impaired in the presence of nOGT
since it is known that expression of TRAK1/2 results in mitochondrial
clustering. This is supported by the imaging of cytoplasmic,
aggregated mitochondria summarized in Fig. 8I.
In summary, it has been shown that TRAK1 and TRAK2 serve as
signalling platforms linking the conventional kinesin-1 motor
proteins to their cargoes. An integral component of this complex is
the post-translational enzyme, OGT. Results reported here support a
possible functional role for O-glycosylation in the formation of this
complex although the precise mechanism has yet to be elucidated. It
appears from the literature that TRAK1 and TRAK2 may have a broad
speciﬁcity in terms of the cargoes whose transport they facilitate. The
study here focused onmitochondria since they are the best candidates
for cargoes being anterogradely trafﬁcked via the TRAK1/TRAK2
kinesin adaptors [10]. Furthermore, the majority of the ﬁndings
regarding the formation of the ternary complex and the protein–
protein interactions therein were carried out employing over-
expression in mammalian cells. It will be important to translate
these ﬁndings into a more physiological context. Post-translational
modiﬁcation by OGT is likely to regulate multiple processes in
neurones however the ﬁndings reported here may be exploited to
investigate its importance in regulating mitochondrial transport. For
example, one may envisage that the use of dominant negatives to
inhibit deﬁned protein–protein interactions within the kinesin/TRAK/
OGT complexwill be insightful in terms of determining the function of
each to the transport of neuronal mitochondria. These extended
studies will contribute to the elucidation of the signalling pathways
that lead to the formation of these trafﬁcking complexes yielding
insights into the emerging ﬁeld of the regulated dynamics of
mitochondrial movement which seems to be especially important in
neuronal cells (reviewed in [32–36].Acknowledgements
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